Nasdaq Podd News Today

Headlands Technologies LLC purchased a new position in Insulet Co. (NASDAQ:PODD – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 395 shares of the medical instruments supplier’s stock, valued at approximately $86,000. Other hedge funds and […]

Stevens Capital Management LP lessened its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 79.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,494 shares of the medical instruments supplier’s stock after selling 5,890 shares during the period. Stevens Capital Management […]

Abrdn plc cut its position in Insulet Co. (NASDAQ:PODD – Free Report) by 3.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 305,354 shares of the medical instruments supplier’s stock after selling 11,574 shares during the quarter. abrdn plc owned about […]

Impax Asset Management Group plc cut its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,451 shares of the medical instruments supplier’s stock after selling 216 shares during the period. […]

Impax Asset Management Group plc trimmed its position in Insulet Co. (NASDAQ:PODD – Free Report) by 13.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,451 shares of the medical instruments supplier’s stock after selling 216 shares during the period. Impax Asset Management Group plc’s holdings in Insulet were worth $315,000 as […]

Eastern Bank lowered its position in Insulet Co. (NASDAQ:PODD – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 49,910 shares of the medical instruments supplier’s stock after selling 1,319 shares during the quarter. Eastern Bank owned […]

Shares of Insulet Co. (NASDAQ:PODD – Get Free Report) have earned an average rating of “Moderate Buy” from the sixteen ratings firms that are covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 12-month price target among […]

Wolff Wiese Magana LLC raised its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 2,680.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 139 shares of the medical instruments supplier’s stock after purchasing an additional 134 shares during the quarter. […]

Insulet Co. (NASDAQ:PODD – Free Report) – Research analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for shares of Insulet in a research note issued to investors on Friday, February 23rd. Leerink Partnrs analyst M. Kratky anticipates that the medical instruments supplier will post earnings per share of $7.84 for the year. […]

Insulet Co. (NASDAQ:PODD – Free Report) – Analysts at William Blair raised their Q1 2024 earnings per share (EPS) estimates for shares of Insulet in a research report issued on Friday, February 23rd. William Blair analyst M. Kaczor now forecasts that the medical instruments supplier will earn $0.43 per share for the quarter, up from […]